ArticleFrontiers in cardiovascular medicine2026
Use of intraoperative right ventricular strain as a predictor of outcomes in adult heart transplant patients.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Right ventricle (RV) evaluation in the perioperative period is challenging for anesthesiologists, given the limited objective assessment methods available for transesophageal echocardiography (TEE). Speckle-tracking strain imaging may offer a more objective evaluation of RV function. This study evaluated the predictive value of intraoperative RV free wall strain (RVFWS) for early outcomes following orthotopic heart transplantation (OHT). Methods: This was a single-center retrospective cohort study of 147 adults who underwent isolated OHT between January 2025 and December 2025. Patients with multiorgan transplant, congenital cases, and those without measurable intraoperative RVFWS were excluded. Post-bypass RVFWS was measured using TEE at a single time point with speckle-tracking analysis. The primary outcome was 90-day mortality. Secondary outcomes included severe primary graft dysfunction, 30-day mortality, need for postoperative venoarterial extracorporeal membrane oxygenation and continuous renal replacement therapy (CRRT), vasoactive-inotropic score, and cardiac index at 24 and 72 h, and intensive care unit length of stay. Multivariable Firth-penalized logistic and median quantile regressions were used, adjusted for Results: The median post-bypass RVFWS was -13.9% IQR (interquartile range) -19.3 to -9.6. Fourteen recipients (9.5%) died within 90 days of transplantation. After adjusting for the pre-transplant risk score, RVFWS was independently associated with higher 90-day mortality [odds ratio (OR) 2.84 per 5% decrease in magnitude, 95% confidence interval 1.65-5.58; Conclusions: Intraoperative post-bypass RVFWS is a feasible and objective intraoperative measure that is independently associated with early adverse outcomes after adult OHT. RVFWS shows promise as a signal of early allograft dysfunction that is not fully explained by pre-transplant risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.